Summary & Overview
CPT 21013: Excision of Soft Tissue Tumor, Face or Scalp
CPT code 21013 denotes surgical excision of a soft tissue tumor on the face or scalp, with tissue submitted for pathology to rule out cancer. This procedure is clinically important because facial and scalp masses, while often benign, require removal and histologic evaluation to exclude malignancy and to guide further care. Nationally, appropriate coding of these excisions affects both clinical documentation and payment for surgical services performed in ambulatory surgery centers, hospital outpatient departments, and office-based surgical settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, common payers and payer considerations, and the types of benchmarks and policy details typically associated with surgical excision codes. The publication summarizes expected sites of service and the clinical rationale for sending specimens for laboratory analysis. It also outlines the range of modifiers commonly encountered for surgical services and notes where input was not provided.
This resource is intended for billing professionals, surgeons, and policy analysts seeking a national overview of CPT code 21013, its clinical purpose, and the payer landscape relevant to coding and claims processing.
Billing Code Overview
CPT code 21013 describes excision of a soft tissue tumor from the face or scalp. The procedure involves removal of an abnormal soft tissue growth—commonly a lump or bump—from facial or scalp tissues and submission of the specimen for laboratory analysis to exclude malignancy.
-
Service type: Surgical excision of a soft tissue tumor
-
Typical site of service: Ambulatory surgical center or hospital outpatient/office-based surgical setting
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient presents to an outpatient dermatology clinic with a 1.2 cm, mobile, painless subcutaneous nodule on the scalp that has slowly increased in size over several months. The provider performs a focused history and physical exam, documents lesion size, location, and appearance, counsels the patient on risks and benefits, obtains informed consent, and schedules an excision. On the day of service the patient receives local anesthesia and the clinician performs a complete excision of the soft tissue tumor, achieves hemostasis, and closes the wound. The specimen is labeled and submitted for pathological examination to determine benign versus malignant histology. Typical site of service is an outpatient ambulatory surgical center or dermatology office procedure room; hospital outpatient departments may also be used for patients with comorbidities or complex lesions. Billing is submitted for the excision procedure with specimen handling and pathology reported separately as appropriate. Payors commonly involved include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service | Use when another procedure performed at the same session is separate and not normally reported together with the excision (e.g., two unrelated procedures at different anatomic sites). |